Compositions and methods to inhibit kidney stone growth
AssigneeKidney Stone Research Company, Inc.
InventorsGregory K. Hayer, Brendan Magrab, Henry R. Wolfe, Jr.
Life of this patent
Estimating the term…
Abstract
An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
Claims4
An oral dosage form or a plurality of dosage forms comprising three ingredients selected from citric acid, magnesium citrate, phytin, pyridoxine, and musa.
A method of treating or inhibiting formation of kidney stones comprising administering to a patient in need thereof an oral dosage form or a plurality of dosage forms comprising three ingredients selected from citric acid, magnesium citrate, phytin, pyridoxine, and musa.
A method of inhibiting growth of calcium oxalate crystals comprising contacting an aqueous solution comprising calcium oxalate with an oral dosage form or a plurality of dosage forms comprising three ingredients selected from citric acid, magnesium citrate, phytin, pyridoxine, and musa.
Dependencies are inferred from the claim text.